Abstract

Mild TBI (mTBI), which affects 75% of TBI survivors or more than 50 million people worldwide each year, can lead to consequences including sleep disturbances, cognitive impairment, mood swings, and post-traumatic epilepsy in a subset of patients. To interrupt the progression of these comorbidities, identifying early pathological events is key. Recent studies have shown that microbleeds, caused by mechanical impact, persist for months after mTBI and are correlated to worse mTBI outcomes. However, the impact of mTBI-induced blood-brain barrier damage on neurons is yet to be revealed. We used a well-characterized mouse model of mTBI that presents with frequent and widespread but size-restricted damage to the blood-brain barrier to assess how neurons respond to exposure of blood-borne factors in this pathological context. We used immunohistochemistry and histology to assess the expression of neuronal proteins in excitatory and inhibitory neurons after mTBI. We observed that the expression of NeuN, Parvalbumin, and CamKII was lost within minutes in areas with blood-brain barrier disruption. Yet, the neurons remained alive and could be detected using a fluorescent Nissl staining even 6 months later. A similar phenotype was observed after exposure of neurons to blood-borne factors due to endothelial cell ablation in the absence of a mechanical impact, suggesting that entrance of blood-borne factors into the brain is sufficient to induce the neuronal atypical response. Changes in postsynaptic spines were observed indicative of functional changes. Thus, this study demonstrates That exposure of neurons to blood-borne factors causes a rapid and sustained loss of neuronal proteins and changes in spine morphology in the absence of neurodegeneration, a finding that is likely relevant to many neuropathologies.

Highlights

  • Traumatic brain injury affects more than 69 million people worldwide every year (Dewan et al, 2018), leading to chronic comorbidities such as sleep disorders, neuroendocrine dysregulation, post-traumatic epilepsy, or psychiatric problems (Bramlett and Dietrich, 2015)

  • To assess how neurons respond to leakage of blood-borne factors after Mild TBI (mTBI), we used retro-orbital injections of cadaverine linked to AlexaFluor-555 to label areas with blood-brain barrier (BBB) damage (Armulik et al, 2010; Mizee et al, 2013)

  • We used the pan-neuronal protein NeuN, which is widely used in the literature, to quantify neurons

Read more

Summary

Introduction

Traumatic brain injury affects more than 69 million people worldwide every year (Dewan et al, 2018), leading to chronic comorbidities such as sleep disorders, neuroendocrine dysregulation, post-traumatic epilepsy, or psychiatric problems (Bramlett and Dietrich, 2015). Some of the candidate mechanisms to induce these comorbidities include edema, focal lesions with tissue loss and subdural hemorrhage (van Asch et al, 2010; Jha et al, 2019; Turtzo et al, 2021). These mechanisms are not present in mild TBI (mTBI), which affects 75% of TBI survivors. The early cellular and molecular events triggered by microbleeds that may be at the root of long-term challenges after mTBI have not been fully identified

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call